Quick Heal Technologies Ltd (QUICKHEAL) — shareholding pattern, promoter holding, financials and share price
About Quick Heal Technologies Ltd (QUICKHEAL)
Quick Heal Technologies Ltd operates in the Software Products industry, within the Information Technology sector. It trades on the NSE as QUICKHEAL and on the BSE under scrip code 539678. Its ISIN is INE306L01010.
Quick Heal Technologies is engaged in the business of providing security software products. The Company caters to both domestic and international market.
Quick Heal Technologies Limited is an Indian cybersecurity firm offering consumer and enterprise security solutions under the Quick Heal and Seqrite brands, founded in 1995 and publicly listed since 2016; it runs Seqrite Labs, serves over 8 million active devices across 70+ countries, holds nine patents, and employs roughly 1,000 cybersecurity professionals focused on product-led innovation.
Q3 FY26 showed Net Revenue of ₹71.5 crore (+1.3% YoY) with very high gross margins (~96%), a small positive EBITDA of ₹0.5 crore, and a sharp Q3 PAT increase to ₹6.6 crore; 9M FY26 revenue was ₹212.3 crore (-1% YoY) while enterprise revenue grew materially and consumer revenue declined, signaling a transition in revenue mix.
Listed peers in Software Products: Unicommerce eSolutions Ltd, TAC Infosec Ltd, Subex Ltd, IRIS Regtech Solutions Ltd, ABM Knowledgeware Ltd, Virtual Galaxy Infotech Ltd.
Valuation & Returns
10 Jul 2026At ₹167.6 a share on 10 Jul 2026, Quick Heal Technologies Ltd (QUICKHEAL) was valued at a price-to-earnings ratio of -83.2x against an industry P/E of 17.23x and a price-to-book of 2.06x on a book value of ₹81.37 per share as of Mar 2025. Solomo computes return on equity of -2.48% and return on capital employed of -4.63% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.
- P/E
- -83.2x
- Industry P/E
- 17.23x
- P/B
- 2.06x
- EPS (TTM)
- ₹-2.01
- Book value / share
- ₹81.37
- ROE
- -2.48%
- ROCE
- -4.63%
- ROA
- -2.08%
- Debt / equity
- 0x
- Dividend yield
- 0%
- EBITDA margin
- -2.51%
- 52-week range
- ₹125 – ₹398.95
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Quick Heal Technologies Ltd (QUICKHEAL) reported revenue of ₹261 crore, net profit of ₹-11 crore and earnings per share of ₹-2.01. That compares with revenue of ₹280 crore and net profit of ₹5 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹49 crore and net profit ₹-20 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 342 | 278 | 292 | 280 | 261 |
| Net profit (₹ cr) | 83 | 6 | 24 | 5 | -11 |
| EPS (₹) | 14.34 | 1.21 | 4.53 | 0.93 | -2.01 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -0.73% | -0.27% | -6.46% | -4.19% |
| Profit growth | -23.54% | -40.33% | -58.55% | -79.21% |
| Stock price CAGR | -4% | -12% | 0% | -58% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 71.48% of Quick Heal Technologies Ltd (QUICKHEAL) (down 0.02 pp QoQ), foreign institutional investors (FII) hold 0.46% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹909 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2015.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 71.48% | - | 0.46% | 0% | 28.52% |
| Mar 2026 | 71.5% | - | 0.73% | 1.16% | 28.5% |
| Dec 2025 | 71.54% | - | 0.45% | 2.29% | 28.46% |
| Sep 2025 | 71.63% | - | 0.5% | 2.33% | 28.37% |
| Jun 2025 | 71.79% | - | 1.16% | 2.58% | 28.21% |
| Mar 2025 | 71.82% | - | 2.02% | 2.63% | 28.18% |
| Dec 2024 | 71.92% | - | 1.81% | 2.84% | 28.08% |
| Sep 2024 | 72.08% | - | 1.61% | 2.62% | 27.92% |